Written by and in paid partnership with CBR® Fresh Test & CBR Team Up Again to Support Expecting Families

When two parent-focused brands come together, something powerful happens. That’s why we’re so excited to announce that CBR® (Cord Blood Registry) is once again partnering with Fresh Test, the all-natural, OB/GYN-endorsed glucose screening alternative.

Together, we’re on a mission to make prenatal care more informed, more empowering, and more aligned with what parents want.

Why Fresh Test?

Fresh Test is revolutionizing the gestational diabetes screening experience. Their beverage is:

• Women-owned and OB/GYN-trusted
• Free of dyes, additives, and preservatives
• Non-GMO and delicious (seriously — 10 out of 10 women in a clinical study preferred it!)

It’s a refreshing alternative to the traditional glucose drink, and it’s making waves in prenatal care.

Why CBR?

CBR is more than just the world's largest and most experienced private newborn stem cell bank in the world — it’s a trusted partner for families looking to invest in their child’s future health. With over 30 years of experience and more than 1 million newborn stem cell samples stored, CBR has helped thousands of families preserve a potentially life-saving resource: their baby’s cord blood and cord tissue.

It's estimated stem cells from cord blood have already been used in over 50,000 stem cell transplants worldwide from donor and private family banks, helping rebuild healthy blood and immune systems. And the future looks even brighter. Over 500 clinical trials have been initiated globally to explore how cord blood and cord tissue may play a role in regenerative medicine.

Cord blood stem cells can already be used to help treat more than 80 conditions, including certain cancers, blood disorders, and immune system diseases. But that’s not all. More than 80% of the cord blood released for CBR families has been intended for use in experimental regenerative medicine applications, such as:

• Cerebral palsy
• Acquired hearing loss
• Heart defects
• Alzheimer’s disease

Because your baby is always a 100% genetic match to their own newborn stem cells, full siblings have a 75% chance of being at least a partial match, and biological parents are always a partial match, cord blood banking can offer increased peace of mind for the family.

CBR is committed to helping families make informed decisions. That’s why they offer a regularly updated blog filled with:

• Medical breakthroughs in stem cell research
• Pregnancy tips and educational resources
• Real client stories that showcase the impact of newborn stem cell preservation

Whether you're navigating pregnancy or planning for your baby's future, your healthcare provider and CBRs blog are go-to resources for science-backed insights and support.

What’s New This Time?

We’re not just celebrating our renewed partnership, we’re making it easier than ever for families to take action:

• CBR Discount: Use code FRSH at cordblood.com for 50% off shipping, processing, and your first year of storage.

Plus, CBR now offers the option to add pediatric genetic testing to your CBR order. This exclusive offering goes beyond standard newborn screening to analyze up to 1,500+ genes related to conditions such as:

• Blood disorders
• Cancers
• Cardiovascular conditions
• Epilepsy
• Hearing and vision loss
• Immunodeficiency disorders
• Metabolic disorders

Using a simple cheek swab, CBR’s genetic tests help identify potential risks early, allowing families to take proactive steps toward treatment, lifestyle changes, or preventive care. In some cases, early detection could even be lifesaving.

One Goal, Two Brands, Endless Possibilities

Whether you’re sipping your Fresh Test or planning for your baby’s future health with CBR, we’re here to support you every step of the way. Because when it comes to your family’s future, informed choices matter.

Visit cordblood.com and thefreshtest.com to learn more and take advantage of these exclusive offers while they last!

Note: Genetic testing is currently available only to parents residing in the U.S.